Invivyd, Inc. - Common Stock (NQ:IVVD)

0.5892 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Invivyd, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 19, 2023

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...

Via Benzinga

Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday ↗

December 19, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDAQ: BLUE) shares fell sharply during Tuesday’s session after the company...

Via Benzinga

Topics Stocks

Nasdaq Gains 100 Points; Biomerica Shares Spike Higher ↗

December 18, 2023

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07....

Via Benzinga

Topics Stocks

Recap: Invivyd Q3 Earnings ↗

November 09, 2023

Via Benzinga

Invivyd's Earnings: A Preview ↗

November 08, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Invivyd ↗

June 23, 2023

Via Benzinga

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 18, 2023

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 18, 2023

Via Benzinga

Crude Oil Rises 3%; US Housing Market Index Increases In December ↗

December 18, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500...

Via Benzinga

Topics Stocks

Why Is COVID-19 Antibody Focused Invivyd Stock Trading Over 150% Higher Today? ↗

December 18, 2023

Invivyd Inc (NASDAQ: IVVD) shares are trading higher after the company released initial results from the ongoing CANOPY Phase 3 pivotal clinical trial of VYD222, a broadly neutralizing, half-life...

Via Benzinga

Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19

December 18, 2023

From Invivyd

Via GlobeNewswire

Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights

November 09, 2023

From Invivyd

Via GlobeNewswire

Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights

November 02, 2023

From Invivyd

Via GlobeNewswire

Invivyd to Participate in Upcoming Investor Conferences

October 31, 2023

From Invivyd

Via GlobeNewswire

Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19

September 11, 2023

Initial primary endpoint data anticipated in late 2023 or early Q1 2024

From Invivyd

Via GlobeNewswire

7 Biotech Stocks to Sell in September Before They Crash & Burn ↗

September 06, 2023

These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues.

Via InvestorPlace

Invivyd to Participate in Upcoming Investor Conferences

September 06, 2023

From Invivyd

Via GlobeNewswire

Invivyd Appoints William Duke as Chief Financial Officer

September 05, 2023

From Invivyd

Via GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Dentsply, and Invivyd on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 16, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 10, 2023

Via Benzinga

Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights

August 10, 2023

From Invivyd

Via GlobeNewswire

Invivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results and Business Highlights

August 03, 2023

From Invivyd

Via GlobeNewswire

Invivyd Announces Appointment of Sara Cotter to Board Of Directors

July 27, 2023

From Invivyd

Via GlobeNewswire

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

INVIVYD INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Invivyd, Inc. – IVVD, ADGI

July 21, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Invivyd's COVID-19 Antibody Shows Favorable Safety, Tolerability Profile For Immunocompromised People ↗

July 17, 2023

Invivyd Inc (NASDAQ: IVVD) announced additional initial data from its ongoing Phase 1 healthy volunteer clinical trial of its lead investigational monoclonal

Via Benzinga

Invivyd Announces Additional Positive Initial Data from Ongoing Phase 1 Clinical Trial of VYD222, a Monoclonal Antibody Candidate in Development for the Prevention of Symptomatic COVID-19 in Immunocompromised People

July 17, 2023

From Invivyd

Via GlobeNewswire

INVIVYD INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Invivyd, Inc. – IVVD, ADGI

July 07, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Invivyd Announces General Alignment with FDA on Pathway to Potential EUA for VYD222 and Anticipated Follow-On Monoclonal Antibody Candidates Designed to Prevent COVID-19

June 26, 2023

From Invivyd

Via GlobeNewswire

Invivyd Says Investigational Antibody Shows Potential To Prevent Symptomatic COVID-19 ↗

June 22, 2023

Invivyd Inc (NASDAQ: IVVD) announces initial data from its ongoing Phase 1 healthy volunteer clinical trial of VYD222, its investigational monoclonal

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.